MedPath

Investigating the effect of caffeine in increasing the level of consciousness of patients with benzodiazepine poisoning

Phase 3
Recruiting
Conditions
Benzodiazepine poisoning.
Poisoning by, adverse effect of and underdosing of benzodiazepines
T42.4
Registration Number
IRCT20091116002717N2
Lead Sponsor
Shahid Beheshti University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
60
Inclusion Criteria

Age above 14 years old
Benzodiazepine poisoning has been confirmed through the urine toxicology screen of the patient
Loss of consciousness
GCS less than 13
No head trauma
Do not have any contraindications to receiving flumazenil
No accompanying poisoning

Exclusion Criteria

Age below 14 years
Not having a positive urine screen for benzodiazepines
No loss of consciousness
GCS 14 15
Having head trauma
Having a contraindication to receiving flumazenil
Having accompanying poisoning
Allergy to caffeine
Having underlying metabolic disease

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.